Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-347860
Filing Date
2012-08-09
Accepted
2012-08-09 17:01:11
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d351669d10q.htm 10-Q 300870
2 EX-31.1 d351669dex311.htm EX-31.1 8402
3 EX-32.1 d351669dex321.htm EX-32.1 3597
  Complete submission text file 0001193125-12-347860.txt   2809826

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ttnp-20120630.xml EX-101.INS 353749
5 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20120630.xsd EX-101.SCH 32898
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20120630_cal.xml EX-101.CAL 35282
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20120630_def.xml EX-101.DEF 38801
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20120630_lab.xml EX-101.LAB 239294
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20120630_pre.xml EX-101.PRE 173967
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27436 | Film No.: 121021128
SIC: 2836 Biological Products, (No Diagnostic Substances)